Opening Asia for Russia

Indian Pharmaceutical Company Receives Permission to Produce Sputnik Light

22.03.2022 98 просмотров

The Sputnik Light vaccine was the first one-component vaccine authorized in India.


Indian pharmaceutical company HETERO said on Monday that it has received approval from the Central Drug Standards Control Organization (CDSCO) to manufacture and sell the Russian-developed Sputnik Light vaccine for limited emergency use in India. Hetero is the first biopharmaceutical company in India to be approved for manufacturing and the marketing of such a drug, manufactured in India itself for the prevention of COVID-19 in adults over the age of 18, administered in a single dose, the TV channel indicates.

significantly high titers of antibodies against COVID-19, both glycoprotein-specific and virus-neutralizing antibodies <...> Sputnik Light also showed neutralizing activity against the micron variant of SARS CoV. -2,” Hetero’s senior vice president Shubhadeep Sinha was quoted as saying.

The Hyderabad-based company manufactures various types of pharmaceuticals, including the Russian vaccine Sputnik V. and last year it mastered the production of a one-component preparation "Sputnik Light" also of Russian design.

As corr. TASS Senior Researcher at HETERO Rajendra Kumar, the company sees great promise in the Sputnik Light vaccine as other currently used vaccines in India require two doses.

Новости партнёров